Dali Pharmaceuticalco.,Ltd
SSE:603963.SS
1.18 (CNY) • At close February 7, 2025
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | ||||||||||||
| Nettowinst
| -20.031 | -17.702 | -41.891 | 3.232 | 13.505 | 10.7 | 44.452 | 62.166 | 62.293 | 100.07 | 92.032 | 94.594 |
| Afschrijvingen & Amortisatie
| 16.005 | 17.85 | 17.505 | 15.934 | 16.345 | 18.145 | 18.535 | 17.647 | 17.812 | 18.003 | 1.743 | 1.601 |
| Uitgestelde Inkomstenbelasting
| 0 | 0.704 | -0.361 | 0.544 | 4.452 | -5.115 | -3.331 | 0 | 0 | 0 | 0 | 0 |
| Aandelen Gebaseerde Vergoedingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verandering in Werkkapitaal
| -19.141 | 1.165 | 7.322 | -18.91 | -16.402 | 53.558 | -39.841 | 7.963 | 35.085 | -22.897 | 0 | 0 |
| Vorderingen
| 4.149 | 1.407 | 2.637 | 6.252 | 10.736 | -19.29 | -16.147 | -0.12 | 10.643 | -1.563 | 0 | 0 |
| Voorraden
| -33.224 | -1.398 | 15.411 | -11.027 | 7.895 | 47.088 | -61.9 | 7.642 | 1.273 | -4.094 | 0 | 0 |
| Crediteuren
| 9.934 | 0.453 | -10.365 | -14.679 | -39.485 | 30.875 | 41.536 | 0 | 0 | 0 | 0 | 0 |
| Overig Werkkapitaal
| 0 | 0.704 | -0.361 | 0.544 | 4.452 | 6.47 | 22.058 | 0.321 | 33.812 | -18.804 | 0 | 0 |
| Overige Niet-Contante Posten
| -2.838 | -5.042 | 27.573 | -6.612 | -6.119 | -4.287 | 3.77 | 0.907 | -0.325 | 0.679 | -92.032 | -94.594 |
| Kasstroom uit Operationele Activiteiten
| -26.007 | -3.729 | 10.509 | -6.356 | 7.329 | 78.115 | 26.917 | 88.683 | 114.865 | 95.854 | 106.594 | 100.746 |
| Investeringsactiviteiten: | ||||||||||||
| Investeringen in Materiële Vaste Activa
| -7.699 | -29.473 | -24.193 | -23.807 | -21.868 | -3.613 | -38.413 | -3.222 | -6.036 | -21.053 | -38.225 | -77.455 |
| Netto Overnames
| 0 | 0 | 0 | 23.932 | 21.868 | -0 | 38.419 | 3.222 | 6.036 | 21.233 | 38.227 | 77.455 |
| Aankoop van Beleggingen
| -340 | -364 | -372 | -240 | -225 | -225 | -254.3 | -70 | -130 | -130 | -67 | -37 |
| Verkoop/verval van Beleggingen
| 362 | 273.117 | 486.86 | 231.332 | 231.534 | 242.02 | 33.302 | 109.777 | 153.676 | 70.988 | 76.745 | 18.056 |
| Overige Investeringsactiviteiten
| 6.06 | -0 | 0 | -23.807 | -21.868 | -0 | -38.413 | -3.222 | -6.036 | -21.053 | -38.225 | -77.455 |
| Kasstroom uit Investeringsactiviteiten
| 20.362 | -120.356 | 90.667 | -32.35 | -15.333 | 13.407 | -259.406 | 36.555 | 17.64 | -79.884 | -28.478 | -96.399 |
| Financieringsactiviteiten: | ||||||||||||
| Schuldaflossingen
| -19.75 | -10.525 | 30 | 20 | 0 | -50 | 30 | -30 | 0 | 25 | -5 | 3.5 |
| Uitgifte van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | -10.96 | 0 | 0 | 0 | 0 | 0 |
| Terugkoop van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| -1.637 | -2.21 | -10.106 | -0.594 | -10.01 | -10.628 | -57.315 | -92.79 | -94.305 | -88.89 | -76.733 | -0.827 |
| Overige Financieringsactiviteiten
| -2.614 | 0 | -3.744 | -0 | 0 | 0 | 261.083 | 0 | -0.72 | -0.4 | 0 | 0 |
| Kasstroom uit Financieringsactiviteiten
| -24 | -12.735 | 16.15 | 19.406 | -10.01 | -60.628 | 233.768 | -122.79 | -95.025 | -64.29 | -81.733 | 2.673 |
| Overige Informatie: | ||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 0 | -0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 |
| Netto Kasstroomverandering
| -29.645 | -136.82 | 117.326 | -19.3 | -18.015 | 30.894 | 1.279 | 2.447 | 37.48 | -48.32 | -3.617 | 7.02 |
| Kaspositie aan het Einde van de Periode
| 14.194 | 43.839 | 180.659 | 63.333 | 82.633 | 100.648 | 69.754 | 68.475 | 66.028 | 28.548 | 76.867 | 80.485 |